← Leaderboards
Alisa Lee Sherick
University Of Colorado Denver
$876,425
Attributed
$876,425
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $175.3K · FY2018–22$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$876,425 · 1
By mechanism
K08$876,425 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Elizabeth J Shpall$12,617,686
- Antonio Jimeno$15,496,689
- George S Eisenbarth$13,354,570
- Jill E Slansky$5,160,564
- Valerie A Fadok$1,470,620
Others in their field
Other Emerging Leaders on “Clinically Relevant”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Bambra Strokes · Ppd Development Lp$65,000,267
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
Clinically RelevantClinical ResearchAnimal ModelAcute Myeloid Leukemia CellAffectAcute Myelocytic LeukemiaApoptosisApoptoticAnti-CancerBaseBlocking AntibodiesAntigen PresentationAntigen-Presenting CellsCancer PatientCancer TherapyCareer DevelopmentCell CommunicationCell DeathCellsAttenuatedCheckpoint ReceptorsClinical CandidateClinical DevelopmentCross Presentation
Grant awards (5)
Targeting MerTK as an immunotherapeutic strategy in acute myeloid leukemia$175,285
K08 · FY2022 · CA · contact PI
Targeting MerTK as an immunotherapeutic strategy in acute myeloid leukemia$175,285
K08 · FY2021 · CA · contact PI
Targeting MerTK as an immunotherapeutic strategy in acute myeloid leukemia$175,285
K08 · FY2020 · CA · contact PI
Targeting MerTK as an immunotherapeutic strategy in acute myeloid leukemia$175,285
K08 · FY2019 · CA · contact PI
Targeting MerTK as an immunotherapeutic strategy in acute myeloid leukemia$175,285
K08 · FY2018 · CA · contact PI